Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

Rakovina Therapeutics Inc. , a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, announces continued advancement of its AI-driven drug discovery program.

Cardiovascular diseases (CVDs) are the key factors leading to death and disability worldwide. This severe challenge has prompted the scientific research and ...

A 0.95 mm biomedical robot from the Hong Kong University of Science and Technology promises to revolutionize minimally invasive surgery.

Know Labs, Inc. is pleased to announce the official launch of its structured client engagement process for Know Labs Technology Licensing (KTL), ensuring a seamless pathway for corporations, ...